Tag: DBV Technologies

Jigsaw Puzzle

Milk and Peanut Clinical Trial Advances

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.
DBV Patch Closeup

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.

Viaskin Peanut Phase III Trial Falls Short, Still Chance for FDA...

The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.
DBV Patch Closeup

DBV Completes Phase III Study of Peanut Patch

The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.
Packaged Foods

Study: Peanut Immunotherapy Significantly Reduces Risks Due to Cross-Contact in Common...

The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.

Viaskin Peanut Patch: Lasting Response After Three Years

Pediatric patients responded with a favorable safety profile and no serious adverse effects.

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.
DBV Patch Closeup

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.

Nestlé Partners with DBV to Develop Milk Allergy Test

The world's largest food business forays into allergy diagnostic services to help sell infant formula.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Connect with Us

30,497FansLike
92FollowersFollow
4,734FollowersFollow
36SubscribersSubscribe